Figure 3 has shown that mRNA expression of S100A8 (HR = 1.84, 95%CI: 1.05–3.23, P = 0.031), S100A11 (HR = 2.02, 95%CI: 1.06–3.85, P = 0.029) and S100B (HR = 2.04, 95%CI: 1.16–3.58, P = 0.012) were related with worse survival in wild-TP53-type ovarian cancer patients, while, S100A2 (HR = 0.45, 95%CI: 0.22–0.93, P = 0.027), S100A3 (HR =0.41, 95%CI: 0.23–0.74, P = 0.0023) and S100A5 (HR = 0.39, 95%CI: 0.18–0.86, P = 0.016) were related with better OS in wild-p53-type EOC patients. This evidence concerns the gene S100B and ovarian cancer.